Chemical Biology and Drug Design
Chemical Biology and Drug Design
3 years ago

Anticancer activity of VmCT1 analogs against MCF-7 cells

Anticancer activity of VmCT1 analogs against MCF-7 cells
Anderson Orzari Ribeiro, Cibele Nicolaski Pedron, Gislaine Patricia Andrade, Giselle Cerchiaro, Vani Xavier Oliveira Junior, Marcelo Der Torossian Torres, Roseli Hiromi Sato
Antimicrobial peptides are considered promising drug candidates due to their broad range of activity. VmCT1 (Phe-Leu-Gly-Ala-Leu-Trp-Asn-Val-Ala-Lys-Ser-Val-Phe-NH2) is an α-helical antimicrobial peptide that was obtained from the Vaejovis mexicanus smithi scorpion venom. Some of its analogs showed to be as antimicrobial as the wild type and they were designed for understanding the influence of physiochemical parameters on antimicrobial and hemolytic activity. Some cationic antimicrobial peptides exhibit anticancer activity so VmCT1 analogs were tested in order to verify the anticancer activity of this family of peptides. The analogs were synthesized, purified, characterized and the conformational studies were performed. The anticancer activity was assessed against MCF-7 mammary cancer cells. The results indicated that [Glu]7-VmCT1-NH2, [Lys]3-VmCT1-NH2 and [Lys]7-VmCT1-NH2 analogs presented moderated helical tendency (0.23 to 0.61) and tendency of anticancer activity at 25 μmol L−1 in 24 hours of experiment; and [Trp]9-VmCT1-NH2 analog that presented low helical tendency and moderated anticancer activity at 50 μmol L−1. These results demonstrated that single substitutions on VmCT1 led to different physicochemical features and could assist on the understanding of anticancer activity of this peptide family. This article is protected by copyright. All rights reserved. VmCT1 and analogs with antimicrobial activity were tested in order to verify the anticancer activity against MCF-7 mammary cancer cells of this family of peptides. The results indicated that some analogs presented moderated helical tendency (0.23 to 0.61) and tendency of anticancer activity at 25 µmol L-1, and that single substitutions on VmCT1 led to different physicochemical features and could assist on the understanding of anticancer activity of this peptide family.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/cbdd.13123

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.